APA (7th ed.) Citation

van Laar, J. M., Lei, A., Safy‐Khan, M., Almquist, J., Belfield, G., Edman, K., . . . Keen, C. (2023). AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study. CTS: Clinical & Translational Science, 16(12), 2494. https://doi.org/10.1111/cts.13624

Chicago Style (17th ed.) Citation

van Laar, Jacob M., et al. "AZD9567 Versus Prednisolone in Patients with Active Rheumatoid Arthritis: A Phase IIa, Randomized, Double‐blind, Efficacy, and Safety Study." CTS: Clinical & Translational Science 16, no. 12 (2023): 2494. https://doi.org/10.1111/cts.13624.

MLA (9th ed.) Citation

van Laar, Jacob M., et al. "AZD9567 Versus Prednisolone in Patients with Active Rheumatoid Arthritis: A Phase IIa, Randomized, Double‐blind, Efficacy, and Safety Study." CTS: Clinical & Translational Science, vol. 16, no. 12, 2023, p. 2494, https://doi.org/10.1111/cts.13624.